C&R Research Inc.
Research C&R Research Inc. (359090.KQ) on Bullrun: market cap KRW 27.07B, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker359090.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyKRW
- Market capKRW 27.07B
- Dividend yield2.1%
- Financial periodQ2 2026
- RevenueKRW 17.78B
- Net incomeKRW 817.82M
- Free cash flowKRW 1.81B
- Gross margin100.0%
Valuation Snapshot
latest market cap is KRW 27.07B; dividend yield is 2.1%.
Peer valuation comparison
Latest dividend yield is 2.12% versus a Healthcare sector median of 2.4% (11.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 27.07B | n/a | 2.1% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 KRW, yield 2.1%.
About C&R Research Inc.
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is C&R Research Inc.'s market cap?
C&R Research Inc.'s market capitalization is KRW 27.07B.
Does C&R Research Inc. pay a dividend?
C&R Research Inc. has a dividend yield of 2.1%.
What does C&R Research Inc. do?
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.